| 2023-05-09 | Sale | Alkermes plc ALKS | director | 41,250 0.0252% | $31.24 | $1.29M | -9.28% | |
| 2020-02-24 | Alkermes plc ALKS | director | 13,880 0.0087% | $19.65 | $272,742 | -9.66% | ||
| 2019-03-14 | Alkermes plc ALKS | director | 890 0.0006% | $33.06 | $29,423 | -36.21% | ||
| 2019-02-21 | Alkermes plc ALKS | director | 7,714 0.005% | $33.09 | $255,256 | -33.96% | ||
| 2012-05-14 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Commercial Officer | 180,000 0.0846% | $64.27 | $11.57M | -18.47% | |
| 2012-05-08 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Commercial Officer | 38,009 0.0174% | $62.10 | $2.36M | -17.78% | |
| 2012-05-07 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Commercial Officer | 147,695 0.0655% | $54.50 | $8.05M | -9.24% | |
| 2012-01-19 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Commercial Officer | 6,042 0.0029% | $37.00 | $223,554 | +30.51% | |
| 2011-12-12 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Commercial Officer | 5,000 0.0024% | $28.90 | $144,500 | +57.24% | |
| 2011-11-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Commercial Officer | 606 0.0003% | $29.77 | $18,041 | +55.39% |